Anixa Biosciences Inc. (NASDAQ: ANIX) announced it has entered into a development and manufacturing agreement with Cytovance Biologics to produce ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE